| Bioactivity | WK692 is a BCL6 inhibitor that inhibits the BCL6BTB/SMRT interaction. WK692 can effectively inhibit the growth of diffuse large B-cell lymphoma cells and synergize with EZH2 and PRMT5 inhibitors.[1]. |
| CAS | 2694055-38-2 |
| Formula | C26H28Br2N8O5 |
| Molar Mass | 692.36 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Xing Y, et al. A Small-Molecule BCL6 Inhibitor as an Anti-Proliferative Agent for Diffuse Large B-Cell Lymphoma[J]. Molecular Cancer Therapeutics, 2024: OF1-OF12. |
WK692
CAS: 2694055-38-2 F: C26H28Br2N8O5 W: 692.36
WK692 is a BCL6 inhibitor that inhibits the BCL6BTB/SMRT interaction. WK692 can effectively inhibit the growth of diffus
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.